About us

Peter Yim, BBA
Director, Outreach and Partnerships

As PREVENT's Director of Outreach and Partnerships, Mr. Yim is responsible for building awareness of and relationships with academia, industry, governments, and international non-governmental organizations and private sector partners and providing marketing support.

Mr. Yim facilitates and fosters initiatives that provide the organization with focus and the capacity to harness funding opportunities that will ensure PREVENT's long term sustainability. This includes engaging the services of external parties with expertise in partnership development, where necessary.

Through partnership building and understanding, research companies, corporations, foundations and the public healthcare sector can more effectively work together to provide vaccines to address Canadian public health priorities.

Mr. Yim was born in Shanghai, China, and was raised in Hong Kong. After finishing high school, he moved to Austin, Texas, where he attended the University of Texas and received a Bachelor of Business Administration (BBA) degree.

After returning to Hong Kong, Mr. Yim took a position with a textile company as an international sales and marketing representative.

In 1978, Mr. Yim came to Canada and was hired by Merck Sharp and Dohme as a professional service representative.

In 1982, the company expanded and created the Merck Frosst Division and Mr. Yim was recruited to join the new venture. In 1983, he was promoted to the position of hospital specialist representative and, subsequently, to senior hospital representative, focusing on infectious diseases and antibiotics.

In 1996, Mr. Yim joined the Merck Vaccine Division and promoted a number of novel vaccine products, during which time he received the highest award in the Division for outstanding performance.

In 1998, Mr. Yim was further promoted to the position of Regional Business Manager (Western Canada), leading, motivating, and developing direct reports to aspire to higher levels of competency and success, establishing benchmarks of excellence to build stellar relationships with both internal and external customers.

From 2003- 2007, Mr. Yim was a medical science liaison in the Merck Frosst Cardiovascular Division and subsequently the Urology Division, developing profiles and identifying areas of professional interest to motivate a change in perception amongst stakeholders and key opinion leaders.

Phone: (306) 966-1533; Deprecated: Function split() is deprecated in /cwis/aliases/prevent-cecr/include/lib.inc on line 60 peter.yim@usask.ca


Did you know?
image of E. coli bacteria

Escherichia coli (E. coli), is a bacterium commonly found in the lower intestine of warm-blooded animals. Most E. coli strains are harmless and are part of the normal beneficial flora of the gut, but some, such as serotype O157:H7, can cause serious food poisoning in humans. Ingestion of contaminated water or food is the usual causes of illness from E. coli.

BACKGROUNDER

Immunization:
Inoculation and Vaccination

Inoculation (also known as variolation) was introduced to the west by Lady Mary Wortley Montagu (1689-1762), who witnessed inoculation being
portrait of lady
practiced by physicians in Constantinople,[12] and was greatly impressed:[13] she had lost a brother to smallpox and bore facial scars from the disease herself. In 1718 she had the embassy surgeon inoculate her son, and in 1721, after returning to England, had her daughter inoculated[14]. In 1722 the Prince of Wales' daughters received inoculations[16].

The practice of inoculation slowly spread amongst the royal families of Europe, followed by general adoption amongst the rest of the population. Given the severe consequences of smallpox in Europe in the 18th century, many parents felt that the benefits outweighed the risks and so inoculated their children.[21] [22]

... more